RhumbLine Advisers’s Chemomab Therapeutics CMMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.2K | Buy |
9,969
+4,007
| +67% | +$18.6K | ﹤0.01% | 3677 |
|
|
2025
Q1 | $26K | Buy |
5,962
+10
| +0.2% | +$44 | ﹤0.01% | 3697 |
|
|
2024
Q4 | $43.1K | Sell |
5,952
-941
| -14% | -$6.81K | ﹤0.01% | 3682 |
|
|
2024
Q3 | $43.3K | Buy |
6,893
+1,924
| +39% | +$12.1K | ﹤0.01% | 3701 |
|
|
2024
Q2 | $18.3K | Buy |
4,969
+312
| +7% | +$1.15K | ﹤0.01% | 3885 |
|
|
2024
Q1 | $14.5K | Hold |
4,657
| – | – | ﹤0.01% | 3810 |
|
|
2023
Q4 | $9.5K | Buy |
4,657
+3,946
| +555% | +$8.05K | ﹤0.01% | 3870 |
|
|
2023
Q3 | $2.54K | Sell |
711
-40
| -5% | -$143 | ﹤0.01% | 4089 |
|
|
2023
Q2 | $3.94K | Buy |
+751
| New | +$3.94K | ﹤0.01% | 4123 |
|